BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21440338)

  • 21. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
    Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
    J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
    Yarim M; Koksal M; Schepmann D; Wünsch B
    Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Santagada V; Caliendo G
    Bioorg Med Chem Lett; 2010 May; 20(9):2978-82. PubMed ID: 20347301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
    J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
    Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
    Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
    Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
    J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.
    Haney KM; Zhang F; Arnatt CK; Yuan Y; Li G; Ware JL; Gewirtz DA; Zhang Y
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5159-63. PubMed ID: 21820898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bivalent bendamustine and melphalan derivatives as anticancer agents.
    Scutaru AM; Wenzel M; Gust R
    Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
    Boksa J; Charakchieva-Minol S; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Bojarski AJ
    Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3406-10. PubMed ID: 16677812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
    Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
    Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
    Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R
    J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
    Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
    Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Putey A; Suzenet F; Joseph B; Bojarski A; Finaru A; Guillaumet G
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):301-5. PubMed ID: 19874209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
    Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
    J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syntheses, antiproliferative activity and theoretical characterization of acitretin-type retinoids with changes in the lipophilic part.
    Magoulas GE; Bariamis SE; Athanassopoulos CM; Haskopoulos A; Dedes PG; Krokidis MG; Karamanos NK; Kletsas D; Papaioannou D; Maroulis G
    Eur J Med Chem; 2011 Feb; 46(2):721-37. PubMed ID: 21208698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.